INTRODUCTION
Erythromycin is a broad spectrum macrolide antibiotic. This compound can be used to substitute penicillin because of the resistence of penicillin to microbes and its sensitivity to some patients. The disadvantage of the usage of erythromycin is the instability in stomach acid [1] omura. The instability is caused by internal nucleophilic attack of hydroxyl group(C-6) to protonated carbonyl (C-9) in macrolide ring [2] . This reaction causes decomposition of erythromycin and lack of its activity. The decomposition can be prevented by structural modifications, because these modifications can prevent the internal nucleophilic attack. Some erythromycin derivative antibiotics produced by structural modification are clarithromycin, roxythromycin and azythromycin [3] .
Macrolide antibiotics able to inhibit the elongation of oligopeptide synthesis in the cavity of rRNA 23S named peptide exit tunnel [4] . The complex structure of macrolide-rRNA 23S D. radiodurans has been found through X-ray crystallography method [5] . Active site of some macrolides (erythromycin-A, roxythromycin and chlarythromycin) in macromolecule rRNA 23S was obtained from X-ray crystallography data [5] . The molecular docking of these molecules are accomplished to determine the mode and strength of binding to rRNA 23S.
As references, molecular docking of chlarythromycin, roxythromycin, 6-deoxyerithromycin-A, -anhidroeritromisin-A is synthesized using biosynthetic engineering technique. This technique comprises of addition of isonizide into Sac. erythraea fermentation [6] [7] [8] [9] . The  6 -anhidroerythromycin-A molecule itself differs from of erythromycin-A due to the presence of  6 double bond and unavailability of hydroxyl molecule (OH) at C-6 in erytronoid ring. The unavailability of hydroxyl molecule (OH) at C-6 is accustomed to increase its stability in acidic solution due to the hydroxyl molecule (OH) at C-6 which is an initiator of erythromycin decomposition [1] . The  6 -anhidroeritromisin-A molecule is experimentally proven to be stable and active until pH 3 [6] .
The molecular docking of 
6
-anhidroerythromycin-A against rRNA 23S is accomplished to determine the model and the strength of binding to rRNA 23S D. radiodurans macromolecule. In order to evaluate the effect of  6 double bond existence and unavailability of hydroxyl molecule (OH) at C-6 in  6 -anhidroeritromisin-A molecule, a comparison model using erythromycin-A and 6-deoxyerythromycin-A molecules were experimented to evaluate the docking model. The binding positions of these molecules resulting from the docking are compared with the site of attachment of erythromycin-A produced by X-ray crystallography based on RMSD (root mean square deviation) calculations. The strength of binding of these molecules from the docking to rRNA 23S macromolecule could be computated based on the free energy of bonding.
EXPERIMENTAL SECTION

Material
Software which is used in this research are: CentOS, Molden, Gaussian98, Chimera, Rasmol and Autodock Tools version 4.01., Protein data bank site (PDB) www.RCSB.org and other sites which are relevant.
Procedure
The complex structure of erytromycin-A with rRNA 23S Deinococcus radiodurans macromolecule is obtained through Protein Data Bank searching via www.RCSB.org. The erythromycin-A structure is seperated from antibiotic macromolecule with the use of CHIMERA programme and saved in PDB format. The structure of  anhidroeritromisin-A and 6-deoksieritromisin-A are drawn using MOLDEN programme and optimalized with ab initio method using Gaussian98 software. The docking of erythromycin-A, 
6
anhidroeritromisin-A and 6-deoxyerythromycin-A to rRNA 23S macromolecule using Autodock version 4.0. The docking parameters used in this research are Lamarckian Genetic Algorithm, grid box 60 and total energy evaluation amounted to 2,5 x 10 8 . The Genetic Algoritm parameter amongst others are 150 initial population, 27.000 maximum generation, cross over rate of 0.8, and mutation rate of 0.02. Local search Solis parameter and Wet including 300 iterations of local search, consecutive successes before changing and 4 consecutive failures before changing.
RESULT AND DISCUSSION
The docking model of  6 -anhidroerythromycin-A, erythromycin-A and 6 deoxyerythromycin-A molecules are executed ten times at the active site of 23S macromolecule by X-ray crystallography [5] . The molecules' relative position of RMSD resulting from docking into erythromycin-A (X-ray) and free energy of binding are shown in From figure 2 it is clear that 6-deoxyerythromycin-A (dock-4) and 
6
-anhidroerythromycin-A (dock-5) molecules' position are not an exact match with erythromycin-A from X-ray crystallography, even tough through RMSD less than 6 Ǻ these molecules are probably occupying peptide exit tunnel of rRNA 23S similar to experimental erythromycin-A. In figure 2 , the macrolide ring of  6 -anhidroerythromycin-A and 6-deoxyerythromycin-A are situated very close to the macrolide ring of erythromycin-A. From this fact, it could be said that both these molecules has the capability of closing the peptide exit tunnel aperture and inhibit polypeptide synthesis elongation as in erythromycin-A.
The relative position of  -anhidroerythromycin-A molecule has made the structural conformation of atom C-5, C-6, C-7 and C-8 to be planar, meanwhile the similar atoms in erythromycin-A and 6-deoxyerythromycin-A does not exist in one domain. The binding position of 6-deoxyerythromycin-A is similar to that of erythromycin-A. This is apparent that the inexistence of a hydroxyl molecule (C-6) in 6-deoxyerythromycin-A molecule does not hamper the binding capabilities with rRNA 23S, as it is not the case with erythromycin-A. As with that, the presence of hydroxyl molecule at C-6 does cause an effect of any nature towards the pharmacological properties of macrolide antibiotic. The difference in binding position between kladinose against erythromycin-A and kladinose against  From table 3 it is clear that the mean free binding energy from ten times of docking erythromycin-A molecule is similar to free binding energy of 6-deoxyerythromycin-A because of the difference in the mean of free binding energy is only 0.43. The difference in free binding energy is not significant in case of value less than 2 kkal/mol [10] . The free binding energy of  Based on docking molecule,  6 -anhidroerythromycin-A which has lower binding energy compared to erythromycin-A therefore it is predicted to have a better antimicrobial potential than of erythromycin-A.
